Hemo Organic Ltd Stock Price Today (NSE: HEMORGANIC)

Hemo Organic Ltd

18.91+0.00 (+0.00%)
Market Closed

Fundamental Score

...

Hemo Organic Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Hemo Organic Ltd share price today is 18.91, up +0.00% on NSE/BSE as of 22 September 2026. Hemo Organic Ltd (HEMORGANIC) is a Small-cap company in the Trading & Distributors sector with a market capitalisation of 8.46 (Cr). The 52-week high for HEMORGANIC share price is 24.42 and the 52-week low is 8.12.

Hemo Organic Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
24.42
Low
18.91
Volume
499.9130434782609
Change
-22.56%

Hemo Organic Ltd share price chart: -22.56% return over the past month. 52-week high ₹24.42, 52-week low ₹8.12.

Hemo Organic Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
18.9118.9118.9118.910.00 (Cr)
18.9118.9118.9118.910.00 (Cr)
18.9118.9118.9118.910.00 (Cr)
18.9118.9118.9118.911.00 (Cr)
19.9019.9019.9019.900.00 (Cr)
19.9019.9019.9019.900.00 (Cr)
19.9019.9019.9019.900.00 (Cr)
19.9019.9019.9019.900.00 (Cr)
19.9019.9019.9019.9025.00 (Cr)
20.9420.9420.9420.940.00 (Cr)

Hemo Organic Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
22.0422.0418.9118.91-14.20%
21.1124.4220.9024.42+15.68%
19.1222.2918.2021.11+10.41%
10.5121.2210.5019.15+82.21%
12.0012.529.7111.00-8.33%
16.0416.0411.7011.70-27.06%
12.9417.0312.3516.36+26.43%
16.8418.5714.0614.33-14.90%
11.9922.5111.9817.18+43.29%
8.4014.038.3611.42+35.95%
9.5411.388.128.40-11.95%
9.0010.928.319.50+5.56%

Returns & Performance

Return on Equity (ROE)

N/A

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

-23.81%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

-24.93%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Hemo Organic Ltd Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

21.65x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Good

Promoter Holding

16.85%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

22.22%

Net profit growth vs same quarter last year

Revenue Growth (Quarterly YoY)

N/A

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

147.57%

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

21.08x

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-2.90 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Hemo Organic Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of HEMORGANIC across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Robust Profit Growth (22.22%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Consistent Growth Track Record (147.57% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

6 factors identified

Suboptimal ROCE (-23.81%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (-24.93%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Elevated Debt Levels (D/E: 21.08)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Negative Free Cash Flow (₹-2.90 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (16.85%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Hemo Organic Ltd vs Trading & Distributors Peers

Peer Comparison - Trading & Distributors

Compare Hemo Organic Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
9.4/100
19
₹8.46
-23.81%
Poor
21.1
Poor
147.57%
Excellent
0.00%
54.7/100
378
₹29554.06
17.4
Average
15.78%
Good
20.17%
Excellent
0.3
Excellent
14.53%
Good
15.91%
Excellent
2.13%
40.8/100
63
₹9414.00
21.1
Average
20.27%
Excellent
23.91%
Excellent
0.0
Excellent
2.89%
Average
-86.37%
Poor
0.00%
Mstc Limited...
MSTCLTD542597
53.6/100
764
₹5379.26
23.0
Average
0.00%
Poor
34.88%
Excellent
0.2
Excellent
14.13%
Good
-13.88%
Poor
6.19%
12.9/100
405
₹2670.18
77.7
Average
8.01%
Poor
4.38%
Poor
0.1
Excellent
0.00%
21.4/100
178
₹2599.08
33.0
Average
16.55%
Good
19.69%
Good
0.2
Excellent
0.06%
28.3/100
637
₹941.52
-13.71%
Poor
-11.12%
Poor
0.2
Excellent
47.55%
Excellent
0.00%
28.2/100
27580
₹808.37
15.5
Average
4.05%
Poor
4.13%
Poor
0.0
Excellent
-14.72%
Poor
4.72%
Average
1.90%
42.4/100
114
₹682.44
11.3
Average
-0.4
Excellent
25.83%
Excellent
0.00%
45.7/100
464
₹631.53
71.8
Average
6.29%
Poor
13.07%
Average
0.8
Good
27.94%
Excellent
14.89%
Good
0.00%
SMTEL...
SMTEL538563
62.59999999999999/100
333
₹601.73
0.55%
Poor
33.16%
Excellent
0.7
Good
154.57%
Excellent
167.25%
Excellent
0.00%

Hemo Organic Ltd Quarterly Performance

Latest quarterly metrics for HEMORGANIC — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

N/A

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

22.22%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

147.57%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Hemo Organic Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for HEMORGANIC — calculated from daily price history

0RSI 14
Oversold — RSI 0

Selling pressure is heavy — potential reversal zone.

SMA 50
22
▼ Price below SMA 50 — Short-term bearish
SMA 200
17
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
2K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Hemo Organic Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Hemo Organic Ltd (HEMORGANIC) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Hemo Organic Ltd

Loading latest quarterly results...

About HEMORGANIC (Hemo Organic Ltd)

Hemo Organic Ltd is a dynamic trading and distribution company focused on connecting the world's bounty with global markets. We specialize in sourcing and delivering a diverse rang...e of premium agricultural products, ensuring quality and freshness at every stage of the supply chain. From fertile fields to discerning consumers, we facilitate the seamless movement of essential commodities, building reliable partnerships with growers and customers alike. Through meticulous attention to detail and a commitment to ethical practices, Hemo Organic Ltd strives to be a trusted leader in the agricultural trading landscape, contributing to sustainable food security and fostering economic growth in the communities we serve. Our core business revolves around the strategic procurement and distribution of key agricultural staples and specialty produce. We handle significant volumes of grains, including wheat, rice, and maize, playing a vital role in feeding populations worldwide. Beyond grains, we expertly manage the supply chain for a variety of fresh vegetables, such as vibrant capsicums, juicy tomatoes, fiery green chilies, versatile potatoes, crisp cucumbers, and flavorful onions. Furthermore, our expertise extends to the sourcing and distribution of luscious fruits, including crisp apples, exotic red dragon fruit, refreshing sweet limes, and ruby-red pomegranates. By offering a comprehensive portfolio of agricultural products, Hemo Organic Ltd serves as a one-stop solution for businesses seeking reliable supply and consistent quality. Driven by a vision of efficiency and integrity, Hemo Organic Ltd leverages advanced logistics and supply chain management technologies to ensure timely and secure delivery of our products. We maintain a robust network of storage facilities and transportation partners, enabling us to reach customers across India and internationally. Our experienced team is dedicated to providing exceptional customer service, building long-lasting relationships based on trust and mutual success. At Hemo Organic Ltd, we are committed to upholding the highest standards of quality, sustainability, and ethical conduct, ensuring that our operations contribute to a healthier planet and a more prosperous future for all.

Company Details

Symbol:HEMORGANIC
Industry:Trading & Distributors
Sector:Trading & Distributors

Key Leadership

Mr. Vishwambar Kameshwar Singh
Chairman & MD
Mr. Murlidhar Joshi
CFO & Director
Ms. Yukta Prakash Patel
Company Secretary & Compliance Officer

HEMORGANIC Share Price: Frequently Asked Questions

What is the current share price of Hemo Organic Ltd?

Hemo Organic Ltd (HEMORGANIC) trades at ₹18.91 on NSE and BSE. Market cap ₹8.46 (Cr). Educational data only.

What is the P/E ratio of Hemo Organic Ltd?

Hemo Organic Ltd has a P/E of N/Ax vs industry average 21.65x.

What is the Bull Run score for Hemo Organic Ltd?

Hemo Organic Ltd has a Bull Run score of 9.4/100 based on 25+ financial parameters.

Does Hemo Organic Ltd pay dividends?

Hemo Organic Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Hemo Organic Ltd?

Hemo Organic Ltd has ROE of N/A. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Hemo Organic Ltd?

Hemo Organic Ltd has debt-to-equity of 21.08.

Is Hemo Organic Ltd a good investment?

Bull Run gives Hemo Organic Ltd a score of 9.4/100. This is not investment advice — consult a SEBI-registered advisor.